IL3 and inflammatory bowel disease: Interestingly, IL-3, a major cytokine produced by activated mast cells in the mucosal layer of the intestines [33], is significantly reduced in glucocorticoid-treated patients with inflammatory bowel disease (IBD) [33], emphasizing its importance in the immunomodulatory effect during inflammation.